PEAK6 Investments’s Inovio Pharmaceuticals INO Stock Holding History

PEAK6 Investments’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-359	Closed	-$24K	–	4296
2018 Q3	$24K	Buy	+359	New	+$20K	﹤0.01%	3893

Other funds holding INO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

PEAK6 Investments's INO Position: Q4 2018 in Review

PEAK6 Investments sold out of Inovio Pharmaceuticals (INO) in Q4 2018, closing a stake of 359 shares — an estimated $24K sold.

PEAK6 Investments first reported a position in INO in Q3 2018 and held it in 1 quarter. The position peaked at $24K in Q3 2018. 125 funds tracked by Wall St. Rank hold INO as of Q4 2018.

PEAK6 Investments reported no remaining Inovio Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
PEAK6 Investments sold 359 Inovio Pharmaceuticals shares in Q4 2018, an estimated $24K.
PEAK6 Investments first reported a position in Inovio Pharmaceuticals in Q3 2018 and held it in 1 quarter.
PEAK6 Investments's Inovio Pharmaceuticals position peaked at $24K in Q3 2018.
125 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2018.

Based on PEAK6 Investments's 13F filing for Q4 2018, filed 13 Feb 2019.